As ResMed has outpaced the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc.

ResMed (RMD) is back in focus after reporting higher sales and net income for its second quarter and first half of fiscal 2026, alongside a fresh quarterly dividend declaration of $0.60 per share. See ...

Most Utah retirees assume they’re playing it safe by leaving traditional IRAs untouched until Required Minimum Distributions kick in. But that seemingly conservative strategy could be quietly draining ...

Over the past six months, ResMed’s shares (currently trading at $252.56) have posted a disappointing 11.7% loss, well below ...

At times, it's the most difficult question to answer: if it's such a great company, how come its shares keep falling?

A rival re-emerges, investors brace for impact and the Ozempic scare dissolves. ResMed’s growth story just got more interesting. ... Read More The post Dr Boreham’s Crucible: A rival may be circling, ...

The fund underperformed the MSCI ACWI ex-US Growth Index but outperformed the Morningstar Foreign Large Growth peer group ...

We're in the midst of a significant tech sector downturn. Here's why. The post Why are ASX 200 tech shares down 43% in six ...

You've spent decades building your retirement nest egg. You've paid into Social Security your entire working life. So you ...

Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.

The Certified Roth Conversion Specialist™ (CRCS™) designation launches to certify advisors in Roth conversion analysis ...